Century Therapeutics Cash Flow Statement (2020-2026) | IPSC

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-23.27M-26.01M-28.15M-37.51M-30.99M-30.75M-31.68M-31.26M-33.29M-32.72M-39.40M-28.06M-31.21M-31.23M-35.20M76.56M-32.54M-34.42M-9.55M-21.66M
Depreciation and Depletion (Quarter)
0.94M1.04M1.05M1.16M1.67M2.77M2.84M2.91M3.23M3.35M3.55M3.23M3.46M3.30M3.32M3.22M3.20M3.13M3.55M3.00M
Share-based Compensation (Quarter)
1.71M0.57M1.64M2.38M2.77M2.79M-7.93M3.80M3.29M3.98M3.56M3.21M3.50M3.32M2.66M2.43M2.22M0.89M1.30M1.45M
Gains from Sales and Divestitures (Quarter)
0.28M0.43M0.57M0.16M0.30M0.43M0.49M0.10M0.10M0.10M0.10M0.02M0.02M0.02M1.50M0.48M0.02M0.43M0.02M0.44M
Gains from Investment Securities (Quarter)
0.10M0.19M0.21M0.04M0.06M0.17M5.79M1.11M2.44M4.61M1.06M0.38M0.51M0.66M-0.08M2.34M4.26M1.86M4.18M5.25M
Asset Writedowns and Impairment (Quarter)
4.22M12.14M4.33M6.76M
Non-cash Items (Quarter)
3.36M3.45M0.23M3.47M31.28M28.94M3.21M38.43M24.10M19.08M3.94M18.52M17.54M15.49M5.00M5.65M8.04M9.41M6.13M6.28M
Cash from Operations (Quarter)
-18.49M-23.98M-24.35M86.75M-25.56M-24.24M-22.91M-29.22M-19.25M-13.65M-26.23M-30.25M-27.33M-28.33M-24.22M-34.62M-27.59M-25.58M-16.08M-25.26M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
1.11M1.34M1.32M1.03M0.85M0.65M0.51M0.35M0.21M
Amortization of Deferred Charges (Quarter)
0.08M0.08M0.08M0.08M0.08M0.08M0.07M0.06M0.04M
Depreciation & Amortization (CF) (Quarter)
0.94M1.04M1.05M1.16M1.67M2.77M2.84M2.91M3.23M3.35M3.55M3.23M3.46M3.30M3.32M3.22M3.20M3.13M3.55M3.00M
Change in Working Capital
Change in Account Payables (Quarter)
1.38M-0.58M2.29M-1.50M-2.36M0.71M-1.63M-2.95M-0.51M3.99M-2.89M0.69M-1.88M-0.76M0.48M0.36M-0.36M-0.59M2.16M-1.62M
Change in Accured Expenses (Quarter)
2.61M0.38M-1.19M-1.17M2.27M1.73M1.13M-3.21M1.93M2.93M-2.39M-3.32M-0.24M2.25M2.91M-6.54M0.71M0.44M1.08M-3.96M
Investing Activities
Capital Expenditures (Quarter)
6.65M20.04M16.72M3.80M-3.48M24.02M-21.68M4.99M4.50M3.27M0.98M0.54M0.27M0.47M0.32M0.20M-0.14M0.58M
Change in Acquisitions & Divestments (Quarter)
16.20M14.76M38.01M63.09M57.20M98.86M52.33M79.16M110.49M64.98M29.27M47.17M29.87M51.57M48.18M43.29M42.52M35.89M37.82M28.66M
Cash from Investing Activities (Quarter)
-11.65M-147.05M-20.60M-44.04M12.52M22.66M-4.27M31.34M6.97M4.22M18.60M11.54M-33.86M39.20M30.61M27.93M32.54M24.67M22.36M-112.61M
Financing Activities
Other financing activities (Quarter)
31.35M0.02M-0.02M
Change in Capital Stock
Shares Issued (Quarter)
2.23M0.00M-2.07M0.07M26.75M-26.56M26.56M0.45M0.12M0.30M-0.36M0.37M0.10M0.27M-0.60M0.12M0.05M0.20M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
224.65M-0.47M0.11M26.88M0.05M0.14M0.10M0.45M-10.12M0.30M-0.36M18.20M56.70M0.27M-0.60M0.12M0.05M126.62M
Change in Cash (Quarter)
194.51M-171.50M-44.85M69.59M-12.99M-1.44M-27.09M2.57M-22.39M-9.13M-7.98M-0.51M-4.50M11.14M5.78M-6.57M4.95M-0.91M6.34M-11.25M
Free Cash Flow (Quarter)
-25.14M-44.02M-41.07M82.96M-22.07M-48.26M-1.23M-34.21M-23.75M-16.91M-27.21M-30.79M-27.60M-28.33M-24.22M-35.10M-27.91M-25.78M-15.94M-25.85M
Net Cash Flow (Quarter)
194.51M-171.50M-44.85M69.59M-12.99M-1.44M-27.09M2.57M-22.39M-9.13M-7.98M-0.51M-4.50M11.14M5.78M-6.57M4.95M-0.91M6.34M-11.25M